Sipa1 deficiency–induced bone marrow niche alterations lead to the initiation of myeloproliferative neoplasm
New research explores signal-induced proliferation-associated gene 1 (SIPA1) mutations, the role they play in initiation MPNs, and the potential to use this gene for future MPN therapies.
Blood Advances
In The News
American Journal of Managed Care
In The Literature
American Journal of Hematology European Journal of Haematology